WO2024013712 - OPHTHALMIC DEVICES, SYSTEMS AND/OR METHODS FOR MANAGEMENT OF OCULAR CONDITIONS
National phase entry is expected:
Publication Number
WO/2024/013712
Publication Date
18.01.2024
International Application No.
PCT/IB2023/057223
International Filing Date
14.07.2023
Title **
[English]
OPHTHALMIC DEVICES, SYSTEMS AND/OR METHODS FOR MANAGEMENT OF OCULAR CONDITIONS
[French]
DISPOSITIFS OPHTALMIQUES, SYSTÈMES ET/OU PROCÉDÉS DE GESTION DE CONDITIONS OCULAIRES
Applicants **
BRIEN HOLDEN VISION INSTITUTE LIMITED
Level 4 North Wing, Rupert Myers Building
Gate 14, Barker Street
University of New South Wales
Sydney, New South Wales 2052, AU
Inventors
ESFANDIARIJAHROMI, Hassan
c/o BRIEN HOLDEN VISION INSTITUTE LIMITED
Level 4, Rupert Myers Building, Baker Street
University of New South Wales
Sydney, New South Wales 2052, AU
BACK, Arthur
c/o BRIEN HOLDEN VISION INSTITUTE LIMITED
Level 4, Rupert Myers Building, Baker Street
University of New South Wales
Sydney, New South Wales 2052, AU
Priority Data
63/389,503
15.07.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP Australia
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3220 | |
| EPO | Filing, Examination | 34398 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 15160 |
Total: 53947 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
An ophthalmic lens configured to correct and/or treat at least one condition of the eye (e.g., presbyopia, myopia, hyperopia, astigmatism, binocular vision disorders, night vision image quality, and/or visual fatigue syndrome) comprising: a base power profile; and at least one pulse selected to modify the base power profile.[French]
L'invention concerne une lentille ophtalmique configurée pour corriger et/ou traiter au moins une condition de l'œil (par exemple, la presbytie, la myopie, l'hypermétropie, l'astigmatisme, les troubles de la vision binoculaire, la qualité d'image de vision nocturne et/ou le syndrome de fatigue visuelle) comprenant : un profil de puissance de base ; et au moins une impulsion sélectionnée pour modifier le profil de puissance de base.